Search Results - "Lämmerer, Anna"
-
1
HGG-08. COMBINATORIAL ACTIVITY OF CDK4/6-INHIBITORS AND TRAMETINIB IN PEDIATRIC HIGH-GRADE GLIOMA WITH BRAFV600E MUTATION AND HOMOZYGOUS CDKN2A DELETION
Published in Neuro-oncology (Charlottesville, Va.) (12-06-2023)“…Abstract BRAFV600E mutations occur in 10-15% and homozygous CDKN2A deletions in approximately 40% of adolescent and pediatric high-grad glioma (HGG) and is…”
Get full text
Journal Article -
2
HGG-15. SYNERGISTIC EFFECTS OF COMBINED MEK/CDK4/6 INHIBITOR TREATMENT ON BRAFV600E POSITIVE HIGH-GRADE GLIOMA
Published in Neuro-oncology (Charlottesville, Va.) (18-06-2024)Get full text
Journal Article -
3
ETMR-12. Novel cell models of CNS tumors with BCOR fusion or internal tandem duplication suggest FGFR and PDGFR as promising therapy targets
Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)“…Abstract Central nervous system (CNS) tumors with BCOR internal tandem duplications (CNS-BCOR ITD) are aggressive malignancies recently included in the 2021…”
Get full text
Journal Article